Sherman S, Cohen ES, Amitay-Laish I, Hodak E, Pavlovsky L. IL-17A Inhibitor Switching – Efficacy of Ixekizumab Following Secukinumab Failure. A Single-center Experience. Acta Derm Venereol [Internet]. 2019 May 21 [cited 2024 Nov. 30];99(9):769-73. Available from: https://medicaljournalssweden.se/actadv/article/view/3247